News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Joshua Bauml: The U.S. FDA approved our targeted therapy in combination with for NSCLC with specific EGFR mutations
Photo from Joshua Bauml/X
Sep 27, 2024, 15:04

Joshua Bauml: The U.S. FDA approved our targeted therapy in combination with for NSCLC with specific EGFR mutations

Joshua Bauml, Vice President, Lung Cancer Disease Area Stronghold (DAS) Leader, shared a post on X:

“The U.S. FDA approved our targeted therapy in combination with chemotherapy for patients with previously treated NSCLC with specific EGFR mutations.

This milestone marks J&J Innovative Medicine’s third new indication in six months for this targeted therapy.”

Additional information

Source: Joshua Bauml/X

cancer cancer awareness FDA fight against cancer Global fight against cancer J&J Innovative Medicine Johnson and Johnson Joshua Bauml NSCLC OncoDaily Oncology US FDA
Special Coverage
Blog
Nov 13, 2024, 08:49
Yüksel Ürün: Promising findings on SGLT2 as a biomarker for papillary RCC by Erman Akkus
Blog
Nov 13, 2024, 08:46
Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer
Blog
Nov 13, 2024, 08:39
Eva Blondeaux on safety of pregnancy in BRCA carriers
Blog
Nov 13, 2024, 08:39
What can cancer in ferrets, opossums, and even penguins teach us about cancer in humans - AACR
Blog
Nov 13, 2024, 08:36
Research Is The Reason Nicole Seagriff had options to treat her breast cancer - The Breast Cancer Research Foundation
Blog
Nov 13, 2024, 08:30
Patrick Hwu: Exploring the unique partnership between Moffitt Cancer Center and Iovance Biotherapeutics
Insight
Nov 13, 2024, 08:27
Paolo Tarantino: The promise and challenges of response-adapted trials in breast oncology
Insight
Nov 13, 2024, 07:41
Key Factors in Menstrual Recovery for Pre-menopausal Breast Cancer on Tamoxifen
Insight
Nov 13, 2024, 07:12
Luigi Lorini was awarded the 2024 Martin "Mac" Cheever Excellence in Clinical Trial Design Travel Award for Immunoprevention
Blog
Nov 12, 2024, 23:10
Hesham ElGhazaly: Empowering Women’s Health Through Solidarity
Blog
Nov 12, 2024, 23:07
Helen’s Journey with Breast Cancer - The Max Foundation
Blog
Nov 12, 2024, 22:58
Webinar on Lung Cancer Highlights from ESMO 2024 - SPCC